Premium
Tissue‐type plasminogen activator rescues neurones from serum deprivation‐induced apoptosis through a mechanism independent of its proteolytic activity
Author(s) -
Liot Géraldine,
Roussel Benoit D.,
Lebeurrier Nathalie,
Benchenane Karim,
LópezAtalaya José P.,
Vivien Denis,
Ali Carine
Publication year - 2006
Publication title -
journal of neurochemistry
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.75
H-Index - 229
eISSN - 1471-4159
pISSN - 0022-3042
DOI - 10.1111/j.1471-4159.2006.03982.x
Subject(s) - neuroprotection , plasminogen activator , apoptosis , tissue plasminogen activator , caspase , protein kinase a , biology , kinase , microbiology and biotechnology , chemistry , programmed cell death , pharmacology , endocrinology , biochemistry
Although the mechanism of action of tissue‐type plasminogen activator (tPA) in excitotoxic necrosis is well documented, whether this serine protease can influence the apoptotic cascade remains a subject of debate. Here, we report that tPA protects cultured cortical neurones against apoptotic cell death induced by serum deprivation, an effect associated with a reduction of caspase‐3 activation. Interestingly, blocking tPA proteolytic activity by either tPA stop or neuroserpin did not prevent this neuroprotection. Similarly, prevention of the interaction between tPA and its receptor low‐density lipoprotein receptor‐related protein (LRP) could not alter tPA anti‐apoptotic activity. Interestingly, the survival‐promoting effect of tPA was blocked by the phosphatidylinositol‐3 (PI‐3) kinase inhibitor, LY294002, but not by the mitogen‐activated protein (MAP) kinase inhibitor, U0126. In conclusion, the present demonstration of an anti‐apoptotic effect of tPA, independent of its enzymatic activity, reveals an additional level of complexity in our understanding of this critical mediator of brain physiology and pathology.